Trauma-Sensitive Yoga for Female Veterans With PTSD Who Experienced Military Sexual Trauma
PSLII
Trauma-sensitive Yoga for Female Veterans With PTSD Who Experienced Military Sexual Trauma
1 other identifier
interventional
131
1 country
2
Brief Summary
In this study, we are evaluating the effectiveness of a yoga intervention to treat posttraumatic stress disorder (PTSD), its associated symptoms of chronic pain and insomnia, and biological and physiological responses to trauma and PTSD in women Veterans who experienced military sexual trauma (MST). If effective, this yoga intervention could reduce PTSD symptoms and chronic pain, improve sleep quality, and decrease the body's automatic "fight or flight" stress response and the damage this stress response causes in the body, including heart disease and diabetes. This intervention could improve these women Veterans' quality of life and social functioning, for example, going to work and having satisfying relationships with family and friends. This study may support an innovative, complementary and alternative PTSD treatment for women Veterans who experienced MST. This new, evidence-based PTSD treatment could supplement current PTSD treatments. Clinical guidelines for this yoga intervention could be implemented nationally in the VA health care system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2016
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2015
CompletedFirst Posted
Study publicly available on registry
December 29, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 26, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedResults Posted
Study results publicly available
October 8, 2024
CompletedOctober 8, 2024
September 1, 2024
5.2 years
December 16, 2015
March 28, 2023
September 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinician Assessed PTSD Checklist-5 (CAPS-5): Change in Mean Total Severity Scores From Baseline to 3-months Post-intervention
Clinician-Administered PTSD Scale for DSM-5 also known as CAPS-5 is the gold standard in PTSD assessment. The CAPS-5 is a structured interview that was used to assess current (past month) PTSD symptom severity. The CAPS-5 total symptom severity score is the sum of 20 items, each scored 0-4, to yield a score with a possible range of 0-80. Higher scores mean worse outcome.
Baseline to 3-Months Post-Treatment (3-m PT): 3-m PT data were collected 11-13 weeks after the final session of TCTSY and CPT cohorts, which began in the same week. TCTSY (10 weeks) 3-m PT data collection occurred 2 weeks prior to CPT (12 weeks).
PTSD Symptom Checklist-5 (PCL-5): Change in Mean Total Score From Baseline to 3-month Post-intervention
The PTSD Symptom-Checklist -Version 5 (PCL-5) is a 20-item, self-report instrument that assesses the presence and severity of DSM-V PTSD symptoms in the last month. It was summed for a total severity score ranging from 0-80, with higher scores representing greater symptom severity (worse outcomes). Within group changes in mean total PCL-5 score from baseline to 3-month post-intervention are reported here.
Baseline to 3-Months Post-Treatment (3-m PT): 3-m PT data were collected 11-13 weeks after the final session of TCTSY and CPT cohorts, which began in the same week. TCTSY (10 weeks) 3-m PT data collection occurred 2 weeks prior to CPT (12 weeks).
Secondary Outcomes (14)
Health-related Quality of Life: VR12, Mental Component Summary (MCS): Change in Mean MCS From Baseline to 3-month Post-intervention
Baseline to 3-Months Post-Treatment (3-m PT): 3-m PT data were collected 11-13 weeks after the final session of TCTSY and CPT cohorts, which began in the same week. TCTSY (10 weeks) 3-m PT data collection occurred 2 weeks prior to CPT (12 weeks).
Health-related Quality of Life: VR12, Physical Component: Change in Mean Subscale Score From Baseline to 3-month Post-intervention
Baseline to 3-Months Post-Treatment (3-m PT): 3-m PT data were collected 11-13 weeks after the final session of TCTSY and CPT cohorts, which began in the same week. TCTSY (10 weeks) 3-m PT data collection occurred 2 weeks prior to CPT (12 weeks).
BPI Pain Severity: Change in Total Severity Score From Baseline to 3-months Post-intervention
Baseline to 3-Months Post-Treatment (3-m PT): 3-m PT data were collected 11-13 weeks after the final session of TCTSY and CPT cohorts, which began in the same week. TCTSY (10 weeks) 3-m PT data collection occurred 2 weeks prior to CPT (12 weeks).
BPI Pain Interference: Change in Total Interference Score From Baseline to 3-months Post-intervention
Baseline to 3-Months Post-Treatment (3-m PT): 3-m PT data were collected 11-13 weeks after the final session of TCTSY and CPT cohorts, which began in the same week. TCTSY (10 weeks) 3-m PT data collection occurred 2 weeks prior to CPT (12 weeks).
Changes in C-reactive Proteins (CRP) From Baseline to 3-months Post-intervention; Within Group Changes; Primary Site Only
Baseline to 3-Months Post-Treatment (3-m PT): 3-m PT data were collected 11-13 weeks after the final session of TCTSY and CPT cohorts, which began in the same week.
- +9 more secondary outcomes
Study Arms (2)
Trauma Center Trauma-Sensitive Yoga (TCTSY)
EXPERIMENTAL10-weekly 1-hour TCTSY Sessions
Cognitive Processing Therapy (CPT)
ACTIVE COMPARATOR12-weekly 1.5 hour CPT Sessions
Interventions
(10) 1-hour sessions of trauma sensitive yoga
(12) 1.5 hour sessions of cognitive processing therapy
Eligibility Criteria
You may qualify if:
- Women Veterans who experienced MST
- Diagnosed with PTSD related to MST
- Insomnia
- Willing to participate in either TCTSY or CPT study intervention
You may not qualify if:
- Schizophrenia with significant psychotic symptoms
- Current, active suicidal intent or plan
- Current substance abuse or dependence
- Certain medical conditions that can contribute significantly to psychiatric symptoms, including:
- poorly controlled hypo/hyperthyroidism
- kidney or liver failure
- Dementia
- Moderate or severe traumatic brain injury (TBI) or other cognitive impairment sufficient to interfere with ability to give informed consent
- Pain due to acute injury (\<3 months), post-surgical pain (\<3 months) or pain due to malignancy; pain related to injury and surgery are excluded to reduce risk of exacerbating underlying injury
- Receiving mental health treatment outside of the VA
- Ongoing participation in mental health treatment at odds with study intervention (For Example: yoga, trauma-focused treatment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia, 30033, United States
VA Portland Health Care System, Portland, OR
Portland, Oregon, 97239, United States
Related Publications (4)
Zaccari B, Loftis JM, Haywood T, Hubbard K, Clark J, Kelly UA. Synchronous Telehealth Yoga and Cognitive Processing Group Therapies for Women Veterans with Posttraumatic Stress Disorder: A Multisite Randomized Controlled Trial Adapted for COVID-19. Telemed J E Health. 2022 Mar 29:10.1089/tmj.2021.0612. doi: 10.1089/tmj.2021.0612. Online ahead of print.
PMID: 35357957BACKGROUNDKelly U, Haywood T, Segell E, Higgins M. Trauma-Sensitive Yoga for Post-Traumatic Stress Disorder in Women Veterans who Experienced Military Sexual Trauma: Interim Results from a Randomized Controlled Trial. J Altern Complement Med. 2021 Mar;27(S1):S45-S59. doi: 10.1089/acm.2020.0417.
PMID: 33788599BACKGROUNDZaccari B, Higgins M, Haywood TN, Patel M, Emerson D, Hubbard K, Loftis JM, Kelly UA. Yoga vs Cognitive Processing Therapy for Military Sexual Trauma-Related Posttraumatic Stress Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2023 Dec 1;6(12):e2344862. doi: 10.1001/jamanetworkopen.2023.44862.
PMID: 38064219RESULTO'Doherty L, Whelan M, Carter GJ, Brown K, Tarzia L, Hegarty K, Feder G, Brown SJ. Psychosocial interventions for survivors of rape and sexual assault experienced during adulthood. Cochrane Database Syst Rev. 2023 Oct 5;10(10):CD013456. doi: 10.1002/14651858.CD013456.pub2.
PMID: 37795783DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The study end point of three months post-treatment precluded determination of even longer-term sustained effects of the interventions. The CAPS-5 assessors were not blinded, introducing a risk of bias. The final cohort at Site 1 and the only cohort at Site 2 were conducted in 2020 during the COVID-19 pandemic, resulting in a pivot of study procedures to virtual delivery - which potentially confounded study data during that time.
Results Point of Contact
- Title
- Dr. Ursula Kelly
- Organization
- Atlanta VA Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Ursula A Kelly, PhD MSN BA
Atlanta VA Medical and Rehab Center, Decatur, GA
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2015
First Posted
December 29, 2015
Study Start
January 1, 2016
Primary Completion
February 26, 2021
Study Completion
September 30, 2021
Last Updated
October 8, 2024
Results First Posted
October 8, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share